This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08437/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08437/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB08437/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08437/identifier/chebi/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08437/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08437/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08437
rdf:type
n3:Drug
n3:description
Puromycin is an antibiotic that is a protein synthesis inhibitor by inhibiting translation. Puromycin is used in cell biology as selective agent in cell culture systems. It is toxic to prokaryotic and eukaryotic cells.
n3:group
experimental
owl:sameAs
n7:DB08437 n15:DB08437
dcterms:title
Puromycin
adms:identifier
n9:17939 n10:388623 n11:439530 n12:99444908 n13:DB08437 n14:PUY
n3:IUPAC-Name
n4:271B5808-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B580E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B580D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B580A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B580B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B580C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5806-363D-11E5-9242-09173F13E4C5 n4:271B581E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5804-363D-11E5-9242-09173F13E4C5 n4:271B5807-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5805-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5814-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5815-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B580F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5810-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5812-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5811-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5813-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
53-79-2
n3:Bioavailability
n4:271B581A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B581C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B581D-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B581F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5819-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5818-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B581B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5809-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5816-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5817-363D-11E5-9242-09173F13E4C5